A Cure for Cancer? How CAR T-Cell Therapy is Revolutionizing Oncology

A Cure for Cancer? How CAR T-Cell Therapy is Revolutionizing Oncology

After 2 Patient Deaths, FDA Imposes Partial Clinical Hold on Trial of Xencor Blood Cancer Antibody XmAb14045

After 2 Patient Deaths, FDA Imposes Partial Clinical Hold on Trial of Xencor Blood Cancer Antibody XmAb14045

Miracle Drugs Don’t Always Work— A Rare but Lethal Case of an Immuno-Oncology Backfire

Miracle Drugs Don’t Always Work— A Rare but Lethal Case of an Immuno-Oncology Backfire

MB-102

CD123 is a subunit of the heterodimeric interleukin-3-receptor (IL-3R) which is widely expressed on human hematologic malignancies including acute myeloid leukemia (AML).   In addition, CD123 can be found on the surface of B cell acute lymphoblastic leukemia (B-ALL), hairy cell leukemia, blastic plasmacytoid dendritic cell neoplasm (BPDCN), chronic myeloid leukemia (CML) and Hodgkin’s lymphoma. Of … Συνεχίστε να διαβάζετε MB-102.